Table of Contents
Introduction
Bile Duct Cancer (Cholangiocarcinoma) – Overview
Bile Duct Cancer (Cholangiocarcinoma) – Therapeutics Development
Bile Duct Cancer (Cholangiocarcinoma) – Therapeutics Assessment
Bile Duct Cancer (Cholangiocarcinoma) – Companies Involved in Therapeutics Development
Bile Duct Cancer (Cholangiocarcinoma) – Drug Profiles
Bile Duct Cancer (Cholangiocarcinoma) – Dormant Projects
Bile Duct Cancer (Cholangiocarcinoma) – Discontinued Products
Bile Duct Cancer (Cholangiocarcinoma) – Product Development Milestones
Appendix
Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..2), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..3), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..4), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..5), H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by 4SC AG, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by AbbVie Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by AbGenomics International Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Ability Pharmaceuticals SL, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by ABM Therapeutics Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Advenchen Laboratories LLC, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Agios Pharmaceuticals Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Alphamab Oncology, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Andes Biotechnologies, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Apollomics Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by ArQule Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Ascelia Pharma AB, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Aslan Pharmaceuticals Ltd, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by AstraZeneca Plc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Bavarian Nordic A/S, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Bayer AG, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by BeiGene Ltd, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by BioMed Valley Discoveries Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Boston Biomedical Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Bristol-Myers Squibb Co, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Celldex Therapeutics Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Cellestia Biotech AG, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Celltrion Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Celon Pharma SA, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Clovis Oncology Inc, H2 2019
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline by Coherent Biopharma, H2 2019
【掲載企業】
4SC AG
AbbVie Inc
AbGenomics International Inc
Ability Pharmaceuticals SL
ABM Therapeutics Inc
Advenchen Laboratories LLC
Agios Pharmaceuticals Inc
Alphamab Oncology
Andes Biotechnologies
Apollomics Inc
ArQule Inc
Ascelia Pharma AB
Aslan Pharmaceuticals Ltd
AstraZeneca Plc
Bavarian Nordic A/S
Bayer AG
BeiGene Ltd
Betta Pharmaceuticals Co Ltd
BioMed Valley Discoveries Inc
Boehringer Ingelheim International GmbH
Boston Biomedical Inc
Bristol-Myers Squibb Co
Celldex Therapeutics Inc
Cellestia Biotech AG
Celltrion Inc
Celon Pharma SA
Clovis Oncology Inc
Coherent Biopharma
Convalife
Corcept Therapeutics Inc
CSPC Pharmaceutical Group Ltd
CStone Pharmaceuticals Co Ltd
Curegenix Inc
CytomX Therapeutics Inc
Daiichi Sankyo Co Ltd
Debiopharm International SA
Delcath Systems Inc
Delta-Fly Pharma Inc
Eddingpharm Inc
Eisai Co Ltd
Eli Lilly and Co
Exelixis Inc
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Forma Therapeutics Inc
Fujifilm Holdings Corp
Genentech Inc
Genoscience Pharma
GlaxoSmithKline Plc
GO Therapeutics Inc
Guangdong Zhongsheng Pharmaceutical Co Ltd
H3 Biomedicine Inc
Harbin Gloria Pharmaceuticals Co Ltd
Hutchison MediPharma Ltd
ImCare Biotech LLC
Immunitor Inc
Incyte Corp
Inmune Bio Inc
InnoCare Pharma Ltd
Innopharmax Inc
Intensity Therapeutics Inc
Ipsen SA
J-Pharma Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Johnson & Johnson
Kangen Pharmaceuticals Co Ltd
Karus Therapeutics Ltd
Komipharm International Co Ltd
Leap Therapeutics Inc
Lexicon Pharmaceuticals Inc
Lokon Pharma AB
Luzitin SA
Marino Biotechnology Co Ltd
Mebiopharm Co Ltd
MediciNova Inc
Medivir AB
Merck & Co Inc
Merck KGaA
Mina Therapeutics Ltd
Molecular Templates Inc
Mundipharma EDO GmbH
Nanjing Transthera Biosciences Co Ltd
NanoCarrier Co Ltd
Newish Technology Beijing Co Ltd
Nkarta Inc
Northwest Biotherapeutics Inc
Novartis AG
NuCana Plc
Oasmia Pharmaceutical AB
Oncocross Co Ltd
OncoTherapy Science Inc
Ono Pharmaceutical Co Ltd
Orgenesis Inc
PCI Biotech Holding ASA
Pfizer Inc
Pharma Mar SA
Provecs Medical GmbH
Puma Biotechnology Inc
Puretech Health Plc
QED Therapeutics Inc
Rafael Pharmaceuticals Inc
RedHill Biopharma Ltd
Redx Pharma Plc
RemeGen Ltd
Rgenix Inc
Samyang Holdings Corp
Sanofi
Seald AS
Senhwa Biosciences Inc
Sensei Biotherapeutics Inc
Shanghai Haihe Biopharma Co Ltd
Shanghai Junshi Bioscience Co Ltd
Sichuan Kelun Pharmaceutical Co Ltd
Sillajen Biotherapeutics
Sinocelltech Ltd
Sirnaomics Inc
SMT bio Co Ltd
Sorrento Therapeutics Inc
Starpharma Holdings Ltd
Sun Pharma Advanced Research Company Ltd
SupremeCure Pharma Inc
SynCore Biotechnology Co Ltd
Syndax Pharmaceuticals Inc
SyntheX Inc
Taiho Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
TCR2 Therapeutics Inc
tella Inc
Tempest Therapeutics Inc
Therillia Development Co Inc
Toray Industries Inc
TOT Biopharm Co Ltd
VasGene Therapeutics Inc
Xencor Inc
Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd
Zymeworks Inc
【免責事項】
https://www.marketreport.jp/reports-disclaimer